Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Fish and Richardson
Colorcon
US Army
Express Scripts
Chubb
Federal Trade Commission
QuintilesIMS
Harvard Business School

Generated: November 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020626

« Back to Dashboard

NDA 020626 describes IMITREX, which is a drug marketed by Glaxosmithkline and is included in three NDAs. It is available from four suppliers. Additional details are available on the IMITREX profile page.

The generic ingredient in IMITREX is sumatriptan. There are twenty-four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the sumatriptan profile page.
Summary for 020626
Tradename:IMITREX
Applicant:Glaxosmithkline
Ingredient:sumatriptan
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020626
Medical Subject Heading (MeSH) Categories for 020626
Suppliers and Packaging for NDA: 020626
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
IMITREX sumatriptan SPRAY;NASAL 020626 NDA GlaxoSmithKline LLC 0173-0523 0173-0523-00 6 CONTAINER in 1 BOX (0173-0523-00) > 1 SPRAY in 1 CONTAINER
IMITREX sumatriptan SPRAY;NASAL 020626 NDA GlaxoSmithKline LLC 0173-0524 0173-0524-00 6 CONTAINER in 1 BOX (0173-0524-00) > 1 SPRAY in 1 CONTAINER

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SPRAY;NASALStrength5MG/SPRAY
Approval Date:Aug 26, 1997TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:SPRAY;NASALStrength10MG/SPRAY
Approval Date:Aug 26, 1997TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:SPRAY;NASALStrength20MG/SPRAY
Approval Date:Aug 26, 1997TE:ABRLD:Yes

Expired US Patents for NDA 020626

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline IMITREX sumatriptan SPRAY;NASAL 020626-002 Aug 26, 1997 ➤ Sign Up ➤ Sign Up
Glaxosmithkline IMITREX sumatriptan SPRAY;NASAL 020626-001 Aug 26, 1997 ➤ Sign Up ➤ Sign Up
Glaxosmithkline IMITREX sumatriptan SPRAY;NASAL 020626-001 Aug 26, 1997 ➤ Sign Up ➤ Sign Up
Glaxosmithkline IMITREX sumatriptan SPRAY;NASAL 020626-002 Aug 26, 1997 ➤ Sign Up ➤ Sign Up
Glaxosmithkline IMITREX sumatriptan SPRAY;NASAL 020626-003 Aug 26, 1997 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Queensland Health
Farmers Insurance
Healthtrust
Colorcon
QuintilesIMS
Julphar
Cipla
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.